safety analysis
Showing 26 - 50 of >10,000
Novel Algorithm System for Polypharmacy Patient Medication
Completed
- Polypharmacy Patients
- Multi-drug analysis of polypharmacy treatment
-
Jerusalem, IsraelHadassah Ein Kerem
Oct 18, 2022
Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex
Completed
- Anesthesia, General
- Neuromuscular Blockade
- Sugammadex Injection 2mg/kg
- +3 more
-
Seoul, Jongro Gu, Korea, Republic ofSNUH
Oct 20, 2022
Meibomian Gland Dysfunction, Blepharitis Trial in Alicante (Study group, Control group)
Recruiting
- Meibomian Gland Dysfunction
- Blepharitis
- Study group
- Control group
-
Alicante, SpainAlicante Vissum Miranza
Oct 17, 2022
Progression Free Survival(PFS) Trial (Toposide capsules combined with anrotinib and Emvolizumab group)
Not yet recruiting
- Progression Free Survival(PFS)
- Toposide capsules combined with anrotinib and Emvolizumab group
- (no location specified)
Jan 13, 2023
MS Had Greater Than 60 Infusions of Natalizumab
Active, not recruiting
- Multiple Sclerosis
-
Latham, New YorkMultiple Sclerosis Center of Northeastern New York, P.C.
Mar 23, 2022
Multaq® for Safety in Atrial Fibrillation
Completed
- Atrial Fibrillation
-
Chilly-Mazarin, FranceSanofi-Aventis, France
Apr 20, 2022
Polyethylene Glycols, Children, Only Trial (PEG 3350)
Not yet recruiting
- Polyethylene Glycols
- Children, Only
- PEG 3350
- (no location specified)
Jul 28, 2022
Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Recruiting
- Hematologic Neoplasms
- COVID-19 Vaccines
- S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
- +2 more
-
Vilnius, LithuaniaVilnius University Hospital Santaros Klinikos
Dec 27, 2021
Women Who Underwent Primary and Secondary Breast Augmentation
Recruiting
- Breast Implant; Complications
- +2 more
- Silimed® Textured Silicone Gel-Filled Breast Implant
- Silimed® Polyurethane Foam Covered Silicone Gel-Filled Breast Implant
-
Niterói, Rio De Janeiro, BrazilPerfektua Serviços Médicos Ltda
Jan 11, 2023
Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery
Recruiting
- Coronary Artery Disease
- +3 more
- RuiXin-CoronaryAI software
-
Beijing, Beijing, China
- +2 more
Sep 19, 2022
Climate in the Hybrid Angiography Suite
Completed
- Healthy Volunteers
- Aortic Aneurysm, Abdominal
- Assessment of radiation safety climate
- +3 more
-
Ghent, Oost Vlaanderen, Belgium
- +4 more
Nov 24, 2021
Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)
Completed
- Healthy Adult Volunteers
- ChAdOx1-nCov-19 (Astra-Zeneca)
- SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
-
Taipei City, X, TaiwanNational Taiwan University Hospital
Oct 16, 2022
Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta
Active, not recruiting
- ChAdOx1 nCoV-19 Vaccine
- ChAdOx1 nCoV-19 vaccine
-
Assiut, EgyptAliae AR Mohamed-Hussein
Sep 18, 2021
Outpatient Cervical Ripening
Completed
- Pregnancy
-
Greenville, South CarolinaPrisma Health
May 17, 2022
Desflurane in Automated Gas Control Mode
Completed
- Safety Issues
-
Malatya, TurkeyInonu Univercity
Aug 24, 2021
Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex
Completed
- Anesthesia, General
- Neuromuscular Blockade
- Sugammadex Injection 2mg/kg
- +3 more
-
Seoul, Jongro Gu, Korea, Republic ofSNUH
Feb 8, 2022
VQI DELTA Paclitaxel Device Safety Analysis
Completed
- Peripheral Vascular Disease
- Paclitaxel
- Non-drug coated Device Treatment
-
Burlington, MassachusettsLahey Clinic, Inc.
Oct 13, 2020
Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,
Recruiting
- Luminal B/HER2-negative Breast Cancer
- Dalpiciclib combined with aromatase inhibitors
- anthracycline-cyclophosphamide followed by taxane
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022
Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)
Completed
- Breast Cancer
- Cardiac Toxicity
- trastuzumab
- +11 more
-
Rochester, MinnesotaMayo Clinic Cancer Research Consortium
Jul 12, 2022
Asymptomatic Hyperuricemia Trial in Bengbu (SIBP-R002, Dexamethasone or Methyl prednisolone, Diphenhydramine)
Recruiting
- Asymptomatic Hyperuricemia
- SIBP-R002
- +3 more
-
Bengbu, Anhui, ChinaThe first affiliated hospital of Bengbu medical college
Apr 6, 2022
Pivotal, Single-arm Clinical Trialto Assess Efficacy and Safety
Completed
- Stable Angina
- +2 more
- Collecting invasive FFR measurements.
-
Hadera, Central District, Israel
- +2 more
Apr 5, 2022
Thoracic Aorta, Thoracic Aorta Aneurysm, Thoracic Aorta Abnormality Trial in Milano, Brescia, Barcelona (thoracic endovascular
Recruiting
- Thoracic Aorta
- +2 more
- thoracic endovascular repair
-
Milano, Lombardia, Italy
- +2 more
Sep 18, 2021
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,
Active, not recruiting
- Metastatic Melanoma
- +3 more
- Imiquimod
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 3, 2023
Heart Failure Trial in Cincinnati (Ruboxistaurin)
Withdrawn
- Heart Failure
-
Cincinnati, OhioThe Lindner Center for Research and Education at The Christ Hosp
Jun 1, 2022